Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY: NVS )

99.07 -0.30 (-0.30%)
Official Closing Price Updated: 7:00 PM EST, Jan 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novartis AG Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
42 43 Next >
Can Novartis Move to New Highs and Sustain Them?
Novartis stock is moving higher following outperformance in Q2 and increased guidance. A $15 billion share repurchase authorization is also in play. 
Via MarketBeat
Topics Intellectual Property
Exposures Intellectual Property
Nasdaq Futures Rise As Focus Turns To Tesla, Netflix Q2 Prints: Analyst Says Earnings Need Some 'Heavy Lifting' For Sustained Rally
Via Benzinga
Why Novartis Stock Spiked Today
A massive share buyback program and an improved outlook powered a mid-single-digit rise in the drugmaker's shares today. 
Via The Motley Fool
Novartis Ag (NVS) Q2 2023 Earnings Call Transcript
NVS earnings call for the period ending June 30, 2023. 
Via The Motley Fool
Novartis Puts Up Its Biggest Earnings Growth In Two Years; Shares Pop
Novartis put up more than 17.3% growth in its profit, beating quarterly records since June 2021. 
Via Investor's Business Daily
Earnings Preview For Novartis
Via Benzinga
Expert Opinions on Dry Eye Treatment Innovations
CRANBURY, N.J. - July 13, 2023 - PRLog -- IVIEW Therapeutics Inc. a clinical stage biotechnology company focusing on developing innovative ophthalmic therapeutics, organized a panel of dry eye experts... 
Via PRLog
Exposures Product Safety
(NVS) - Analyzing Novartis's Short Interest
Via Benzinga
NBCUniversal's Peacock Raises Prices First Time Since Launch, Warren Buffett Sells Majority of Activision Blizzard Stake Before Microsoft Deal Approval, Novartis Launches $15B Share Buyback: Today's Top Stories
Wall Street Journal 
Via Benzinga
Novartis Q2 Earnings: Company Lifts Outlook, Launches $15B Share Buyback, Maps Out Sandoz Spin-Off
Novartis AG (NYSE: NVS) reported Q2 FY23 sales of $13.62 billion, up 7% Y/Y and 9% on constant currency, beating the consensus 
Via Benzinga
Nasdaq, S&P 500 Futures Dip Ahead of Big Bank Earnings, Retail Sales Data: Why This Analyst Stays Cautious About Tech Sector
Via Benzinga
Bank of America, Morgan Stanley And 3 Stocks To Watch Heading Into Tuesday
With U.S. stock futures trading slightly lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Why Are BeiGene Shares Trading Lower Today
BeiGene Limited (NASDAQ: BGNE) shares are trading lower after the company mutually agreed to  
Via Benzinga
US Court Issues Negative Decision On Novartis' Heart-Failure Drug Patent
Swiss pharma giant Novartis AG (NYSE: NVS)  
Via Benzinga
Drug Maker Novartis Stock Shows Rising Relative Strength
Novartis stock had its Relative Strength Rating upgraded to 73 Monday -- a nice improvement, but still shy of the preferred 80-plus score. 
Via Investor's Business Daily
MoonLake's Potential Sale: Stock Price Up Fivefold Since Public Debut In 2022
MoonLake Immunotherapeutics (NASDAQ: MLTX) has reportedly engaged an investment bank as the Swiss company looks for a potential sale. The company focuses on developing antibody-derived treatments for... 
Via Benzinga
The Acute Hospital Care Market Is Worth Over $3 Trillion, And Windtree Therapeutics Brings A First-In-Class Drug To An Active Segment Of This Market
The global acute hospital care market was worth $3.2 trillion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.62% from 2023 to 2030. 
Via Benzinga
S&P Makes Weekly Advance As Inflation Reaches Lowest Level Since March 2021; Amazon, Microsoft, Alphabet And Major Banks Lead Market Optimism
The S&P 500 is closing the week in the green in light of positive inflation data. The index was 2.48% higher on the week ahead of the market close Friday. Other major market indexes also showed an... 
Via Benzinga
Why Novartis Stock Slipped on Friday
A major company product lost a key legal protection. 
Via The Motley Fool
Novartis Earnings Conference Call Is Coming Up, Here's What You Need To Know
Via Benzinga
Eli Lilly Unveils A Nearly $2 Billion Deal To Leap Ahead In Weight Loss
The company is hoping to curb the lean muscle mass loss tied to weight-loss drugs. 
Via Investor's Business Daily
The Blazing Weight-Loss Drug Battle: Can Anyone Unseat Undisputed Leaders Novo Nordisk And Lilly?
An overweight world is hungry for new treatments. For now, two companies own the market. 
Via Investor's Business Daily
3 Penny Stocks to Catapult You Into the Millionaires’ Club
These penny stocks can deliver tremendous upside from their depressed range. Wall Street analysts can back it up! 
Via InvestorPlace
Gilead Boosts Biotech Footprint With Stakes In AlloVir And Arcus
Regulatory filings show Gilead Sciences' purchase of shares in AlloVir and Arcus. Strategic investments in the biotech sector are fairly common to boost growth. 
Via MarketBeat
Topics Retirement
Exposures Pension
A Comprehensive Study Exploring Viral Disease Diagnosis Market : Key Players BioMerieux, Prescient Medicine Holdings, Danaher
AMA released Viral Disease Diagnosis Market research study .Check what differences transitions in customer choices may bring? 
Via SBWire
Exposures COVID-19
Medical Management Of Deadly Urgent Cardiogenic Shock Largely Remains A Challenge – Windtree Therapeutics (NASDAQ: WINT) Is Helping Change That
Windtree Therapeutics, Inc. (NASDAQ: WINT), a biotechnology company treating late-stage acute cardiovascular disorders, is advancing its first-in-class drug for serious heart conditions. 
Via Benzinga
3 Biotech Stocks That AI is Loving in July
As AI becomes a more entrenched aspect of society, investors can lean on these AI recommended biotech stocks with predicted high potential. 
Via InvestorPlace
#blackartmatters Series And Inaugural Talk By Gallerist Lewis P. Long
Famed Harlem gallery owner, Lewis P. Long, is set to lead the first talk of #BlackArtMatters, sponsored by Morristown's revered Art in the Atrium.MORRISTOWN, N.J. - July 6, 2023 - PRLog -- Famed Harlem... 
Via PRLog
Bausch + Lomb Expands OTC Eye Care Portfolio, Acquires JNJ's Blink
Bausch + Lomb Corporation (NYSE: BLCO) has acquired Johnson & Johnson's (NYSE: JNJ) eye and contact lens drops brand Blink for $106.5 million to bolster its position in over-the-counter (OTC)... 
Via Benzinga
Meet Chinook Therapeutics, The Company Novartis Is Spending $3.5 Billion To Acquire
Chinook Therapeutics has a history of being opportunistic. Now, it's joining forces with Novartis. 
Via Investor's Business Daily
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
42 43 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.